Suppr超能文献

[终末期肾衰竭中的贫血。发病机制与治疗]

[Anemia in terminal kidney failure. Pathogenesis and therapy].

作者信息

Heilmann E

出版信息

Fortschr Med. 1977 Feb 10;95(6):338-44.

PMID:838456
Abstract

Various factors are involved in the pathogenesis of anemia in dialysis patients. Reduced erythropoiesis is mainly attributed to erythropoietin deficiency. Stimulation of erythropoiesis may be promoted by androgens. Substitution of iron is recommended in case of iron deficiency. As a rule, supplementation of vitamin B12 is not necessary, but administration of folic acid is recommended. Treatment of anemia in renal failure is rendered more effective by increased technical efficiency in hemodialysis permitting a relatively protein-rich diet. Blood transfusions are not necessary during routine treatment of dialysis. Since bilateral nephrectomy will always provoke severe anemia, it should be reserved to special cases of severe hypertension. Until now, no conservative therapy has been developed which would allow optimal treatment of anemia in dialysis patients. Successful renal transplantation still is, and will be, the best therapeutic intervention.

摘要

多种因素参与透析患者贫血的发病机制。红细胞生成减少主要归因于促红细胞生成素缺乏。雄激素可促进红细胞生成。缺铁时建议补充铁剂。通常,无需补充维生素B12,但建议补充叶酸。通过提高血液透析技术效率以允许相对富含蛋白质的饮食,可使肾衰竭贫血的治疗更有效。常规透析治疗期间无需输血。由于双侧肾切除术总会引发严重贫血,应仅用于特殊的严重高血压病例。到目前为止,尚未开发出能对透析患者贫血进行最佳治疗的保守疗法。成功的肾移植过去是、将来也仍将是最佳的治疗干预措施。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验